Regeneron Pharmaceuticals said on Monday its experimental gene therapy showed improved hearing in 10 of 11 children between ...

Pfizer said on Thursday it will stop global development and commercialization of its hemophilia gene therapy, Beqvez, citing ...

A gene therapy from Regeneron Pharmaceuticals Inc. improved hearing in nearly all deaf children in a clinical trial, results ...

Regeneron’s gene therapy, dubbed DB-OTO, is a cell-selective AAV gene therapy for children with hearing loss stemming from a ...

An experimental trial of gene therapy has helped four toddlers - born with one of the most severe forms of childhood ...

OTO, is one of several early-stage gene therapies being developed to treat relatively straight-forward causes of genetic ...

Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.

"We have, for the first time, an effective treatment for the most severe form of childhood blindness, and a potential ...

Hyderabad: Cell and gene therapy solutions provider Miltenyi Biotec on Monday announced the roll-out of what is touted as ...

Miltenyi Biotec opens cell and gene therapy center in Hyderabad, advancing medical research and innovation in Life Sciences.

Miltenyi Biotec launched India's first Cell and Gene Therapy Center in Hyderabad. The Miltenyi Innovation and Technology ...

Revolutionary gene therapy approaches show promise in treating various retinal conditions, potentially transforming treatment ...